Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record.

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

Open access
Reed, Steven G., Coler, Rhea N., Dalemans, Wilfried, Tan, Esterlina V., DeLa Cruz, Eduardo C., Basaraba, Randall J., Orme, Ian M., Skeiky, Yasir A. W., Alderson, Mark R., Cowgill, Karen D., Prieels, Jean-Paul, Abalos, Rodolfo M., Dubois, Marie-Claude, Cohen, Joe, Mettens, Pascal, Lobet, Yves · 2009 · Proceedings of the National Academy of Sciences

Abstract

The development of a vaccine for tuberculosis requires a combination of antigens and adjuvants capable of inducing appropriate and long-lasting T cell immunity. We evaluated Mtb72F formulated in AS02A in the cynomolgus monkey model. The vaccine was immunogenic and caused no adverse reactions. When monkeys were immunized with bacillus Calmette–Guérin (BCG) and then boosted with Mtb72F in AS02A, protection superior to that afforded by using BCG alone was achieved, as measured by clinical parameters, pathology, and survival. We observed long-term survival and evidence of reversal of disease progression in monkeys immunized with the prime-boost regimen. Antigen-specific responses from protected monkeys receiving BCG and Mtb72F/AS02A had a distinctive cytokine profile characterized by an increased ratio between 3 Th1 cytokines, IFN-γ, TNF, and IL-2 and an innate cytokine, IL-6. To our knowledge, this is an initial report of a vaccine capable of inducing long-term protection against tuberculosis in a nonhuman primate model, as determined by protection against severe disease and death, and by other clinical and histopathological parameters.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0712077106

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 167

Metadata

Authors
Reed, S. G., Coler, R. N., Dalemans, W., Tan, E. V., DeLa Cruz, E. C., Basaraba, R. J., Orme, I. M., Skeiky, Y. A. W., Alderson, M. R., Cowgill, K. D., Prieels, J.-P., Abalos, R. M., Dubois, M.-C., Cohen, J., Mettens, P., & Lobet, Y.
Venue
Proceedings of the National Academy of Sciences
Published
2009-02-17
Volume
106
Issue
7
Pages
2301-2306
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2009737104
Cited by
167
References
0
FWCI
13.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. https://app.cochat.ai/papers/10.1073/pnas.0712077106
The paper
Reed, S. G., Coler, R. N., Dalemans, W., Tan, E. V., DeLa Cruz, E. C., Basaraba, R. J., Orme, I. M., Skeiky, Y. A. W., Alderson, M. R., Cowgill, K. D., Prieels, J.-P., Abalos, R. M., Dubois, M.-C., Cohen, J., Mettens, P., & Lobet, Y. (2009). Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0712077106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.